Exelixis | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Acadia Pharmaceuticals USD 765.24M 32.44M 2025-03
Agios Pharmaceuticals USD 1.37B 96.97M 2025-06
Amgen USD 6.21B 330M 2025-03
AstraZeneca USD 44.72B 3.68B 2025-06
Bayer EUR 32.58B 537M 2025-03
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Cytokinetics USD -266413000 131.04M 2025-03
Eisai JPY 828.51B 12.91B 2025-06
Eli Lilly USD 15.85B 1.65B 2025-03
Exelixis USD 2.03B 97.49M 2025-07
Genmab DKK 5.3B 31.4B 2025-03
Glaxosmithkline GBP 13.67B 337M 2024-12
Incyte USD 4.17B 503.34M 2025-06
Ionis Pharmaceuticals USD 631.72M 156M 2025-06
MacroGenics USD 116.06M 4.01M 2024-12
Merck USD 48.34B 2.02B 2025-03
Moderna USD 9.4B 667M 2025-06
Neurocrine Biosciences USD 2.69B 158.6M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Sanofi 77.86B 4.86B 2024-12
Takeda JPY 6.87T 69.82B 2025-06
Ultragenyx Pharmaceutical USD 151.29M 7.04M 2025-06
Xencor USD 639.87M 37.74M 2025-03


Exelixis Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.